Clinical Trial

A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD

Name: A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD — clinical trial record (NCT07717892)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to \<18 years with ADHD.

Trial Details

NCT Number	NCT07717892
Lead Sponsor	Axsome Therapeutics, Inc.
Conditions	ADHD
Enrollment	468 participants
Start Date	2026-06-25
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-21